4.7 Article

Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome

Related references

Note: Only part of the references are listed.
Editorial Material Medicine, General & Internal

The Evolving Story of Triglycerides and Coronary Heart Disease Risk

Ann Marie Navar

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)

Article Endocrinology & Metabolism

Development and Risk Factors of Type 2 Diabetes in a Nationwide Population of Women With Polycystic Ovary Syndrome

Katrine Hass Rubin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)

Article Obstetrics & Gynecology

Placental characteristics in women with polycystic ovary syndrome

Maria P. H. Koster et al.

HUMAN REPRODUCTION (2015)

Article Obstetrics & Gynecology

Pregnancy complications in women with polycystic ovary syndrome

Stefano Palomba et al.

HUMAN REPRODUCTION UPDATE (2015)

Article Public, Environmental & Occupational Health

The 'Developmental Origins' Hypothesis: relevance to the obstetrician and gynecologist

A. J. Kermack et al.

JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE (2015)

Article Public, Environmental & Occupational Health

Toward a Road Map for Global -Omics: A Primer on -Omic Technologies

Steven S. Coughlin

AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)

Article Endocrinology & Metabolism

Low-Grade Chronic Inflammation in Pregnant Women With Polycystic Ovary Syndrome: A Prospective Controlled Clinical Study

Stefano Palomba et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Article Obstetrics & Gynecology

Intrauterine Environment and Polycystic Ovary Syndrome

Daniel A. Dumesic et al.

SEMINARS IN REPRODUCTIVE MEDICINE (2014)

Review Biochemistry & Molecular Biology

The role of phosphatidylcholine and choline metabolites to cell proliferation and survival

Neale D. Ridgway

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)

Article Multidisciplinary Sciences

Plasma Lipid Profiling Shows Similar Associations with Prediabetes and Type 2 Diabetes

Peter J. Meikle et al.

PLOS ONE (2013)

Article Medical Laboratory Technology

Metabolic Heterogeneity in Polycystic Ovary Syndrome Is Determined by Obesity: Plasma Metabolomic Approach Using GC-MS

Hector F. Escobar-Morreale et al.

CLINICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

Plasma Lysophosphatidylcholine Levels Are Reduced in Obesity and Type 2 Diabetes

Melissa N. Barber et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

Dynamic Modification of Sphingomyelin in Lipid Microdomains Controls Development of Obesity, Fatty Liver, and Type 2 Diabetes

Susumu Mitsutake et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Medicine, Research & Experimental

Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans

Eugene P. Rhee et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Biochemistry & Molecular Biology

Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance

Myoung Sook Han et al.

JOURNAL OF LIPID RESEARCH (2011)

Article Biochemistry & Molecular Biology

Reducing Plasma Membrane Sphingomyelin Increases Insulin Sensitivity

Zhiqiang Li et al.

MOLECULAR AND CELLULAR BIOLOGY (2011)

Article Obstetrics & Gynecology

Metabolic parameters in cord blood of newborns of women with polycystic ovary syndrome

Manuel Maliqueo et al.

FERTILITY AND STERILITY (2009)

Article Biochemistry & Molecular Biology

Lysophosphatidylcholine Activates Adipocyte Glucose Uptake and Lowers Blood Glucose Levels in Murine Models of Diabetes

Kyungmoo Yea et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Review Obstetrics & Gynecology

A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome

C. M. Boomsma et al.

HUMAN REPRODUCTION UPDATE (2006)

Article Nutrition & Dietetics

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease

Axel Schlitt et al.

NUTRITION & METABOLISM (2006)